INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 48 filers reported holding INOZYME PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,452 | -33.9% | 18,917 | -12.3% | 0.00% | – |
Q2 2023 | $120,184 | +3938.4% | 21,577 | +661.4% | 0.00% | – |
Q4 2022 | $2,976 | +197.6% | 2,834 | +2364.3% | 0.00% | – |
Q2 2022 | $1,000 | -96.2% | 115 | -98.2% | 0.00% | – |
Q1 2022 | $26,000 | -46.9% | 6,313 | -12.7% | 0.00% | – |
Q4 2021 | $49,000 | +4800.0% | 7,228 | +14958.3% | 0.00% | – |
Q2 2021 | $1,000 | -95.0% | 48 | -95.2% | 0.00% | – |
Q1 2021 | $20,000 | +42.9% | 1,002 | +86.9% | 0.00% | – |
Q3 2020 | $14,000 | – | 536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,009,117 | $26,529,000 | 9.44% |
YALE UNIVERSITY | 113,502 | $2,984,000 | 9.13% |
Sofinnova Investments, Inc. | 2,028,308 | $53,324,000 | 3.95% |
Novo Holdings A/S | 2,569,379 | $67,549,000 | 3.35% |
NEA Management Company, LLC | 2,444,379 | $64,263,000 | 2.72% |
RA Capital Management | 2,003,653 | $52,676,000 | 0.96% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,299 | $30,241,000 | 0.74% |
Rock Springs Capital Management LP | 879,954 | $23,134,000 | 0.59% |
SPHERA FUNDS MANAGEMENT LTD. | 196,411 | $5,164,000 | 0.51% |
Orbimed Advisors | 400,400 | $10,527,000 | 0.13% |